Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1/2, Open-Label, Multicenter Trial With a Single Ascending Dose Cohort With Unilateral Intracochlear Injection Followed by a Bilateral Injection Expansion Cohort to Evaluate the Safety, Tolerability, and Efficacy of DB-OTO in Children and Infants With Biallelic hOTOF Mutations
Regeneron is conducting a study of an investigational new drug called DB-OTO. DB-OTO is a gene therapy that is being developed to treat pediatric and adult par…
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Estimated
~$10 – $8,750
Regeneron PharmaceuticalsNCT05788536
Observational
Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness
The goal of this clinical trial is to investigate the safety and effectiveness of cochlear implantation in infants and toddlers with single-sided deafness. Th…
Single Sided DeafnessUnilateral DeafnessHearing Loss, Unilateral+3 more
Estimated
~$10 – $6,250
University of North Carolina, Chapel HillNCT05775367